Category : Clinical Research, Pharma & Healthcare Financing

bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that it...

Grant funds two-thirds of a NIS 1.23 million ($373K) project to strengthen Scinai Bioservices’ small-batch fill and finish capabilities, addressing a critical need among early-stage biotech companies...

CREATE Medicines, Inc. (formerly Myeloid Therapeutics, Inc.) today announced an expanded strategy to move beyond myeloid-focused in vivo programming toward multilineage immune programming, including T cells, myeloid cells,...

The grants will drive research and development programs in regenerative medicine across Maryland The Maryland Stem Cell Research Commission (the Commission) awarded $4,707,142 in grant funding to...

Diagnostics company Nutromics has presented the world’s first real-time, continuous data on two critical antibiotics – vancomycin and tobramycin – measured simultaneously on the same...

Addressing Critical Unmet Medical Need ExQor Technologies, a Boston MA based biotechnology company, is preparing for clinical trials for its proprietary brain regenerative medicine platform...

Expanded partnership positions XenoSTART and Minerva Imaging at the forefront of radiopharmaceuticals — one of the fastest-growing areas in oncology drug development. The START Center...

Also Closes Amendment to $428.5 Million Term Loan Facility Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) today announced that it has closed...

Over 350,000 members have joined the waitlist since May, underscoring the excitement for one product that can pair blood biomarkers with 24/7 wearable data WHOOP,...

The DNA synthesis inhibitors market is projected to witness substantial growth in the coming years, driven by the rising incidence of cancer diagnoses, growing awareness,...

Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a...

− Treatment with Vutrisiran Led to 37- 49% Lower Rates of Gastrointestinal Events, a Multisystem Manifestation of ATTR-CM, Across Multiple Treatment Groups, Compared to Placebo...

Virometix AG, a Swiss clinical-stage biotechnology company pioneering fully synthetic vaccines, today announced that it has successfully completed enrollment in the Phase I clinical trial...

Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with evidence to support completing course of treatment...

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that it has received a United Kingdom Conformity...